• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖基纳米粒子通过与肽模拟衍生物功能化用于口服药物递送。

Chitosan based nanoparticles functionalized with peptidomimetic derivatives for oral drug delivery.

机构信息

Department of Chemistry, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy.

Istituto di Biochimica e Biochimica Clinica, Università Cattolica del "Sacro Cuore", L.go F. Vito 1, 00168 Rome, Italy.

出版信息

N Biotechnol. 2016 Jan 25;33(1):23-31. doi: 10.1016/j.nbt.2015.07.005. Epub 2015 Aug 7.

DOI:10.1016/j.nbt.2015.07.005
PMID:26257139
Abstract

The goal of this study was to develop an optimized drug delivery carrier for oral mucosa applications able to release in situ bioactive molecules by using biopolymeric materials. Among them chitosan and poly(lactic-co-glycolic acid) (PLGA) have gained considerable attention as biocompatible carriers able to improve the delivery of active agents. The formulation of such vehicles in the form of nanoparticles (NPs) could permit to exploit the peculiar properties of nanomaterials in order to enhance the efficacy of active agents. Chitosan (CS) and PLGA chlorexidine dihydrochloride (CHX)-loaded NPs were synthesized by ionotropic gelation and osmosis based methodology respectively. In order to facilitate NPs adhesion on human dental surfaces, two different strategies were employed: PLGA particles with an external shell of CS to produce a positive surface charge allowing CHX loaded PLGA NPs to interact with the negative charged dental surfaces, while CS particles were functionalized with peptidomimetic derivative glutathione (GSH). The morphology was investigated by scanning electron microscopy. A sustained release profile of CHX from CS NPs was achieved. CS-based NPs adhered on human tooth surfaces in a simulated brushing and rinsing process and their in vitro toxicity evaluation on Human Gingival Fibroblasts (HGFs) was between 20 and 60% in all experimental conditions. Thanks to their adhesion properties and low cytotoxicity, the synthesized CS-based formulations may be efficiently exploited for therapy purposes or to enhance in vivo dental care (i.e. preparation of toothpastes or other cosmetics for daily oral care).

摘要

本研究的目的是开发一种用于口腔黏膜给药的优化药物传递载体,该载体能够使用生物聚合材料原位释放生物活性分子。其中,壳聚糖和聚(乳酸-共-乙醇酸)(PLGA)作为生物相容性载体已引起广泛关注,能够提高活性药物的传递效率。将这些载体制成纳米颗粒(NPs)的形式可以利用纳米材料的特殊性质来增强活性药物的疗效。通过离子凝胶化和渗透压方法分别合成了壳聚糖(CS)和载有氯己定二盐酸盐(CHX)的 PLGA NPs。为了促进 NPs 在人牙表面的黏附,采用了两种不同的策略:PLGA 颗粒的外壳为 CS,产生正表面电荷,允许载有 CHX 的 PLGA NPs 与带负电荷的牙表面相互作用,而 CS 颗粒则被肽模拟物衍生物谷胱甘肽(GSH)功能化。通过扫描电子显微镜研究了形态。CS 纳米颗粒实现了 CHX 的持续释放。CS 基 NPs 在模拟刷牙和冲洗过程中黏附在人牙表面,其对人牙龈成纤维细胞(HGFs)的体外毒性评估在所有实验条件下均在 20%至 60%之间。由于其黏附性能和低细胞毒性,合成的 CS 基制剂可有效地用于治疗目的或增强体内牙齿护理(例如,制备牙膏或其他用于日常口腔护理的化妆品)。

相似文献

1
Chitosan based nanoparticles functionalized with peptidomimetic derivatives for oral drug delivery.壳聚糖基纳米粒子通过与肽模拟衍生物功能化用于口服药物递送。
N Biotechnol. 2016 Jan 25;33(1):23-31. doi: 10.1016/j.nbt.2015.07.005. Epub 2015 Aug 7.
2
Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.载硫喷妥钠 PLGA 纳米粒的制备及体外评价。
Drug Deliv. 2016;23(3):787-93. doi: 10.3109/10717544.2014.916765. Epub 2014 May 28.
3
Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.壳聚糖包覆的聚(乳酸-共-乙醇酸)纳米粒提高 7-乙基-10-羟基喜树碱口服吸收的机制。
Nanotechnology. 2013 Jun 21;24(24):245101. doi: 10.1088/0957-4484/24/24/245101. Epub 2013 May 23.
4
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.海藻酸包覆壳聚糖核壳纳米粒经口递送依诺肝素:体外与体内评价。
Int J Pharm. 2013 Nov 1;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. Epub 2013 Aug 29.
5
Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures.壳聚糖包覆的 PLGA 纳米粒:用于细胞培养的药物持续释放策略。
Colloids Surf B Biointerfaces. 2013 Mar 1;103:310-7. doi: 10.1016/j.colsurfb.2012.10.063. Epub 2012 Nov 20.
6
Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide.壳聚糖修饰的 PLGA 纳米粒口服传递甲苯磺丁脲
Colloids Surf B Biointerfaces. 2018 Jan 1;161:67-72. doi: 10.1016/j.colsurfb.2017.10.037. Epub 2017 Oct 12.
7
Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.具有细胞穿透肽和两亲性壳聚糖衍生物的改性纳米颗粒用于增强胰岛素的口服结肠吸收:制备与评价
Drug Deliv. 2016 Jul;23(6):2003-14. doi: 10.3109/10717544.2015.1048489. Epub 2015 Jul 16.
8
Cytotoxicity and intracellular fate of PLGA and chitosan-coated PLGA nanoparticles in Madin-Darby bovine kidney (MDBK) and human colorectal adenocarcinoma (Colo 205) cells.聚乳酸-羟基乙酸共聚物(PLGA)及壳聚糖包被的PLGA纳米颗粒在马-达二氏牛肾(MDBK)细胞和人结肠腺癌(Colo 205)细胞中的细胞毒性及细胞内命运
J Biomed Mater Res A. 2015 Nov;103(11):3599-611. doi: 10.1002/jbm.a.35498. Epub 2015 Jun 11.
9
Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.用于紫杉醇持续和pH敏感递送的低分子量壳聚糖包被聚合物纳米颗粒。
J Drug Target. 2015;23(7-8):725-35. doi: 10.3109/1061186X.2015.1054829.
10
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.用于多西他赛口服递送的聚丙交酯-维生素E衍生物/蒙脱石纳米颗粒制剂
Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.

引用本文的文献

1
Nanostructured Clays Used as Carriers for Controlled Delivery of Antibacterial Compounds From Direct Restorative Dental Materials: A Scoping Review.纳米结构粘土用作牙科直接修复材料抗菌化合物控释载体的范围综述
Clin Exp Dent Res. 2025 Oct;11(5):e70219. doi: 10.1002/cre2.70219.
2
ChitoHeal gel use on the nasal site for prevention of N95 masks caused pressure injuries: A randomised clinical trial.奇浩尔凝胶用于预防 N95 口罩所致压力性损伤:一项随机临床试验。
Int Wound J. 2023 Oct;20(8):3157-3163. doi: 10.1111/iwj.14193. Epub 2023 Apr 14.
3
Chitosan-induced biomodification on demineralized dentin to improve the adhesive interface.
壳聚糖诱导的脱矿牙本质生物改性以改善粘结界面。
Restor Dent Endod. 2022 Jun 15;47(3):e28. doi: 10.5395/rde.2022.47.e28. eCollection 2022 Aug.
4
Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson's Disease.载有左旋多巴和姜黄素的可生物降解纳米粒子治疗帕金森病。
Molecules. 2022 Apr 28;27(9):2811. doi: 10.3390/molecules27092811.
5
Drug delivery systems for oral disease applications.口服疾病应用的药物输送系统。
J Appl Oral Sci. 2022 Mar 9;30:e20210349. doi: 10.1590/1678-7757-2021-0349. eCollection 2022.
6
Multilayer Films Based on Chitosan/Pectin Polyelectrolyte Complexes as Novel Platforms for Buccal Administration of Clotrimazole.基于壳聚糖/果胶聚电解质复合物的多层膜作为克霉唑口腔给药的新型平台
Pharmaceutics. 2021 Sep 30;13(10):1588. doi: 10.3390/pharmaceutics13101588.
7
Controlled Release of 18-β-Glycyrrhetinic Acid from Core-Shell Nanoparticles: Effects on Cytotoxicity and Intracellular Concentration in HepG2 Cell Line.18-β-甘草次酸从核壳纳米颗粒中的控释:对HepG2细胞系细胞毒性和细胞内浓度的影响
Materials (Basel). 2021 Jul 12;14(14):3893. doi: 10.3390/ma14143893.
8
Engineering Polymeric Nanosystems against Oral Diseases.工程聚合纳米系统对抗口腔疾病。
Molecules. 2021 Apr 13;26(8):2229. doi: 10.3390/molecules26082229.
9
Anti-Inflammatory and Antibacterial Activity of the Chitosan/Chlorhexidine Gel Commercial Preparation for Postexodontia Treatment: An In Vitro Study.用于拔牙后治疗的壳聚糖/氯己定凝胶商业制剂的抗炎和抗菌活性:一项体外研究
Eur J Dent. 2020 Jul;14(3):397-403. doi: 10.1055/s-0040-1714453. Epub 2020 Jul 20.
10
Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.在牙周炎的小鼠模型中,评估肽修饰的 PLGA 纳米颗粒对口腔生物膜的功能。
J Control Release. 2019 Mar 10;297:3-13. doi: 10.1016/j.jconrel.2019.01.036. Epub 2019 Jan 25.